Clinical Trials Logo

Pityriasis Lichenoides clinical trials

View clinical trials related to Pityriasis Lichenoides.

Filter by:
  • None
  • Page 1

NCT ID: NCT03920696 Not yet recruiting - Clinical trials for Pityriasis Lichenoides

Pityriasis Lichenoides : Anatomo-clinical Aspects and Follow-up

EtudePL
Start date: May 1, 2019
Phase:
Study type: Observational

Introduction: Pityriasis lichenoides (PL) is an inflammatory dermatitis of undetermined origin consisting of specific papular lesions reflecting an "indolent" lymphoproliferative state. The current classification is confusing because it mixes semiological and chronological notions. The objectives of this study are to better describe the clinical, epidemiological, histological, phenotypic and evolutionary aspects of PL in an adult population. Methods: Investigators will perform a retrospective cohort study including patients with clinical and histological diagnosis of PL from the coding of the Department of Pathology of Henri-Mondor Hospital and from medical records and photographs of lesions if available, between January 2012 and August 2018. A follow-up telephone interviews will also be proposed to each patient to collect evolution data. Photographs will be systematically reviewed as well as cutaneous samples and a genomic analysis will be performed. Conclusion: Investigators would like to better understand clinical, histological features and evolutionary aspects of PL in an adult population.

NCT ID: NCT03831269 Not yet recruiting - Clinical trials for Pityriasis Lichenoides

Pityriasis Lichenoides Chronica, Role of Streptococcal Infection and Azithromycin

Start date: February 2019
Phase: N/A
Study type: Interventional

Primary outcome: The primary outcome at end of study (EOS) is to compare the therapeutic efficacy of Azithromycin in the treatment of pityriasis lichenoides chronica (PLC) with that of a well-documented line of therapy namely narrow band ultra violet B (nbUVB). Secondary outcomes: 1. To identify the possibility of streptococcal throat infection as a possible underlying etiology in PLC.